eduKateSG · Why Science?
See the immune system as a changing network—connecting cells, tissues, cancer, allergy, ageing, technology platforms and clinical translation
A fact-checked guide to A*STAR’s Singapore Immunology Network and the science of human immune responses in health and disease.
A*STAR describes the Singapore Immunology Network, or SIgN, as a centre of excellence in human immunology that expands immunology knowledge and helps translate discoveries towards clinical applications.
Its current official research pages focus on cancer immunology and immune dysfunction, with interests spanning inflammation, immunotherapy, ageing, allergy and skin disease, supported by immunomonitoring and other technology platforms.
Did you know? Two people can have the same number of an immune-cell type while those cells occupy different states, locations or functional programmes.
This guide provides no diagnosis, allergy testing, vaccine advice or treatment recommendation. Sources were checked 11 November 2026.
Chapter index
Chapters 1–9: human immunology, immune cells, innate and adaptive responses, homeostasis, inflammation, immunophenotyping, flow cytometry, mass cytometry, immunogenomics
Chapters 10–17: cancer immunology, immune dysfunction, allergy, ageing, skin disease, antibodies, biomarkers, clinical monitoring and evidence receipts
Human immunology studies immune development, state, function and variation in people. SIgN’s emphasis on human immunology makes the population, tissue and clinical context central rather than decorative. Chapter 1 follows immune evidence from cells and signals to carefully bounded translational questions, showing students that immunity is a dynamic network shaped by development, exposure, metabolism, microbes, ageing and disease.
Connect mechanisms with appropriately governed human samples and cohorts. A defensible study records the participant or model, tissue, collection time, processing delay, assay panel, reagents, controls, batch, analysis pipeline and meaningful outcome. Flow cytometry, mass cytometry, genomics, imaging and functional assays reveal different layers. Replication and orthogonal measurements help distinguish biology from handling or analytical artefact.
An animal mechanism may not reproduce human immunity. Immune data needs cautious interpretation. A cell count, cytokine, antibody or gene-expression signature cannot diagnose a person by itself; group averages may hide heterogeneity; and preclinical results may not transfer to patients. Qualified clinicians, ethics review, regulated trials and current public-health guidance govern real testing, vaccination and treatment.
Explore “Define human immunology” with a fictional immune-cell dataset or paper network. Define the cell type, tissue, stimulus, measurement, comparator, confounders and validation step, then state what the result cannot support. Draw a human-immunity map. Do not collect samples, test allergies, change medicines or infer a real person’s immune status.
Did you know? Immune cells can change their behaviour without changing their broad label, and the same cell type may help in one tissue or phase while contributing to harm in another. Chapter 1 shows why immunologists combine identity, state, location, timing and function instead of treating one marker as the whole immune system.
Capabilities include cell biology, immunology, oncology, microbiology, genomics, microscopy, computational biology, statistics, clinical research, bioengineering and ethics. Current study and career routes set their own entry requirements. School science builds useful foundations through receptors, feedback, controlled comparisons, probability, graph interpretation and explanations that separate mechanism, prediction and clinical utility.
Innate cells and barriers detect change and coordinate rapid responses. SIgN’s emphasis on human immunology makes the population, tissue and clinical context central rather than decorative. Chapter 2 follows immune evidence from cells and signals to carefully bounded translational questions, showing students that immunity is a dynamic network shaped by development, exposure, metabolism, microbes, ageing and disease.
Measure cell identity, receptors, signals, tissue and timing. A defensible study records the participant or model, tissue, collection time, processing delay, assay panel, reagents, controls, batch, analysis pipeline and meaningful outcome. Flow cytometry, mass cytometry, genomics, imaging and functional assays reveal different layers. Replication and orthogonal measurements help distinguish biology from handling or analytical artefact.
Innate does not mean simple or identical across people. Immune data needs cautious interpretation. A cell count, cytokine, antibody or gene-expression signature cannot diagnose a person by itself; group averages may hide heterogeneity; and preclinical results may not transfer to patients. Qualified clinicians, ethics review, regulated trials and current public-health guidance govern real testing, vaccination and treatment.
Explore “Map innate immunity” with a fictional immune-cell dataset or paper network. Define the cell type, tissue, stimulus, measurement, comparator, confounders and validation step, then state what the result cannot support. Build an innate-response timeline. Do not collect samples, test allergies, change medicines or infer a real person’s immune status.
Did you know? Immune cells can change their behaviour without changing their broad label, and the same cell type may help in one tissue or phase while contributing to harm in another. Chapter 2 shows why immunologists combine identity, state, location, timing and function instead of treating one marker as the whole immune system.
Capabilities include cell biology, immunology, oncology, microbiology, genomics, microscopy, computational biology, statistics, clinical research, bioengineering and ethics. Current study and career routes set their own entry requirements. School science builds useful foundations through receptors, feedback, controlled comparisons, probability, graph interpretation and explanations that separate mechanism, prediction and clinical utility.
B and T cells develop diverse receptors, memory and specialised functions. SIgN’s emphasis on human immunology makes the population, tissue and clinical context central rather than decorative. Chapter 3 follows immune evidence from cells and signals to carefully bounded translational questions, showing students that immunity is a dynamic network shaped by development, exposure, metabolism, microbes, ageing and disease.
Track clonotypes, activation, specificity and durability. A defensible study records the participant or model, tissue, collection time, processing delay, assay panel, reagents, controls, batch, analysis pipeline and meaningful outcome. Flow cytometry, mass cytometry, genomics, imaging and functional assays reveal different layers. Replication and orthogonal measurements help distinguish biology from handling or analytical artefact.
A receptor sequence alone does not prove protective function. Immune data needs cautious interpretation. A cell count, cytokine, antibody or gene-expression signature cannot diagnose a person by itself; group averages may hide heterogeneity; and preclinical results may not transfer to patients. Qualified clinicians, ethics review, regulated trials and current public-health guidance govern real testing, vaccination and treatment.
Explore “Map adaptive immunity” with a fictional immune-cell dataset or paper network. Define the cell type, tissue, stimulus, measurement, comparator, confounders and validation step, then state what the result cannot support. Create an adaptive map. Do not collect samples, test allergies, change medicines or infer a real person’s immune status.
Did you know? Immune cells can change their behaviour without changing their broad label, and the same cell type may help in one tissue or phase while contributing to harm in another. Chapter 3 shows why immunologists combine identity, state, location, timing and function instead of treating one marker as the whole immune system.
Capabilities include cell biology, immunology, oncology, microbiology, genomics, microscopy, computational biology, statistics, clinical research, bioengineering and ethics. Current study and career routes set their own entry requirements. School science builds useful foundations through receptors, feedback, controlled comparisons, probability, graph interpretation and explanations that separate mechanism, prediction and clinical utility.
Immune homeostasis balances defence, tolerance, repair and restraint across tissues. SIgN’s emphasis on human immunology makes the population, tissue and clinical context central rather than decorative. Chapter 4 follows immune evidence from cells and signals to carefully bounded translational questions, showing students that immunity is a dynamic network shaped by development, exposure, metabolism, microbes, ageing and disease.
Measure baseline variation and recovery after perturbation. A defensible study records the participant or model, tissue, collection time, processing delay, assay panel, reagents, controls, batch, analysis pipeline and meaningful outcome. Flow cytometry, mass cytometry, genomics, imaging and functional assays reveal different layers. Replication and orthogonal measurements help distinguish biology from handling or analytical artefact.
A population average is not one universal healthy state. Immune data needs cautious interpretation. A cell count, cytokine, antibody or gene-expression signature cannot diagnose a person by itself; group averages may hide heterogeneity; and preclinical results may not transfer to patients. Qualified clinicians, ethics review, regulated trials and current public-health guidance govern real testing, vaccination and treatment.
Explore “Understand homeostasis” with a fictional immune-cell dataset or paper network. Define the cell type, tissue, stimulus, measurement, comparator, confounders and validation step, then state what the result cannot support. Design a homeostasis study. Do not collect samples, test allergies, change medicines or infer a real person’s immune status.
Did you know? Immune cells can change their behaviour without changing their broad label, and the same cell type may help in one tissue or phase while contributing to harm in another. Chapter 4 shows why immunologists combine identity, state, location, timing and function instead of treating one marker as the whole immune system.
Capabilities include cell biology, immunology, oncology, microbiology, genomics, microscopy, computational biology, statistics, clinical research, bioengineering and ethics. Current study and career routes set their own entry requirements. School science builds useful foundations through receptors, feedback, controlled comparisons, probability, graph interpretation and explanations that separate mechanism, prediction and clinical utility.
| Evidence move | What to record | What it cannot prove alone |
|---|---|---|
| Immune system question | Population, variable, unit and time window | A definition does not establish a result |
| Comparison | Baseline, comparator, controls and uncertainty | Association alone does not establish cause |
| Decision boundary | Owner, trigger, review and escalation | A model does not replace accountable judgement |
Flow cytometry measures selected markers on individual cells at speed. SIgN’s emphasis on human immunology makes the population, tissue and clinical context central rather than decorative. Chapter 5 follows immune evidence from cells and signals to carefully bounded translational questions, showing students that immunity is a dynamic network shaped by development, exposure, metabolism, microbes, ageing and disease.
Plan panels, controls, gating, compensation and quality checks. A defensible study records the participant or model, tissue, collection time, processing delay, assay panel, reagents, controls, batch, analysis pipeline and meaningful outcome. Flow cytometry, mass cytometry, genomics, imaging and functional assays reveal different layers. Replication and orthogonal measurements help distinguish biology from handling or analytical artefact.
A marker combination does not reveal every cell function. Immune data needs cautious interpretation. A cell count, cytokine, antibody or gene-expression signature cannot diagnose a person by itself; group averages may hide heterogeneity; and preclinical results may not transfer to patients. Qualified clinicians, ethics review, regulated trials and current public-health guidance govern real testing, vaccination and treatment.
Explore “Use flow cytometry” with a fictional immune-cell dataset or paper network. Define the cell type, tissue, stimulus, measurement, comparator, confounders and validation step, then state what the result cannot support. Audit a cytometry plot. Do not collect samples, test allergies, change medicines or infer a real person’s immune status.
Did you know? Immune cells can change their behaviour without changing their broad label, and the same cell type may help in one tissue or phase while contributing to harm in another. Chapter 5 shows why immunologists combine identity, state, location, timing and function instead of treating one marker as the whole immune system.
Capabilities include cell biology, immunology, oncology, microbiology, genomics, microscopy, computational biology, statistics, clinical research, bioengineering and ethics. Current study and career routes set their own entry requirements. School science builds useful foundations through receptors, feedback, controlled comparisons, probability, graph interpretation and explanations that separate mechanism, prediction and clinical utility.
Mass cytometry expands simultaneous marker measurement using metal-tagged antibodies. SIgN’s emphasis on human immunology makes the population, tissue and clinical context central rather than decorative. Chapter 6 follows immune evidence from cells and signals to carefully bounded translational questions, showing students that immunity is a dynamic network shaped by development, exposure, metabolism, microbes, ageing and disease.
Control batches, reference samples and high-dimensional analysis. A defensible study records the participant or model, tissue, collection time, processing delay, assay panel, reagents, controls, batch, analysis pipeline and meaningful outcome. Flow cytometry, mass cytometry, genomics, imaging and functional assays reveal different layers. Replication and orthogonal measurements help distinguish biology from handling or analytical artefact.
More markers can amplify artefacts and interpretation choices. Immune data needs cautious interpretation. A cell count, cytokine, antibody or gene-expression signature cannot diagnose a person by itself; group averages may hide heterogeneity; and preclinical results may not transfer to patients. Qualified clinicians, ethics review, regulated trials and current public-health guidance govern real testing, vaccination and treatment.
Explore “Use mass cytometry” with a fictional immune-cell dataset or paper network. Define the cell type, tissue, stimulus, measurement, comparator, confounders and validation step, then state what the result cannot support. Build a panel receipt. Do not collect samples, test allergies, change medicines or infer a real person’s immune status.
Did you know? Immune cells can change their behaviour without changing their broad label, and the same cell type may help in one tissue or phase while contributing to harm in another. Chapter 6 shows why immunologists combine identity, state, location, timing and function instead of treating one marker as the whole immune system.
Capabilities include cell biology, immunology, oncology, microbiology, genomics, microscopy, computational biology, statistics, clinical research, bioengineering and ethics. Current study and career routes set their own entry requirements. School science builds useful foundations through receptors, feedback, controlled comparisons, probability, graph interpretation and explanations that separate mechanism, prediction and clinical utility.
Immunogenomics links gene expression, variation and immune-cell states. SIgN’s emphasis on human immunology makes the population, tissue and clinical context central rather than decorative. Chapter 7 follows immune evidence from cells and signals to carefully bounded translational questions, showing students that immunity is a dynamic network shaped by development, exposure, metabolism, microbes, ageing and disease.
Record sample composition, sequencing depth and multiple-testing control. A defensible study records the participant or model, tissue, collection time, processing delay, assay panel, reagents, controls, batch, analysis pipeline and meaningful outcome. Flow cytometry, mass cytometry, genomics, imaging and functional assays reveal different layers. Replication and orthogonal measurements help distinguish biology from handling or analytical artefact.
Expression differences do not establish causal regulation. Immune data needs cautious interpretation. A cell count, cytokine, antibody or gene-expression signature cannot diagnose a person by itself; group averages may hide heterogeneity; and preclinical results may not transfer to patients. Qualified clinicians, ethics review, regulated trials and current public-health guidance govern real testing, vaccination and treatment.
Explore “Apply immunogenomics” with a fictional immune-cell dataset or paper network. Define the cell type, tissue, stimulus, measurement, comparator, confounders and validation step, then state what the result cannot support. Audit a genomic claim. Do not collect samples, test allergies, change medicines or infer a real person’s immune status.
Did you know? Immune cells can change their behaviour without changing their broad label, and the same cell type may help in one tissue or phase while contributing to harm in another. Chapter 7 shows why immunologists combine identity, state, location, timing and function instead of treating one marker as the whole immune system.
Capabilities include cell biology, immunology, oncology, microbiology, genomics, microscopy, computational biology, statistics, clinical research, bioengineering and ethics. Current study and career routes set their own entry requirements. School science builds useful foundations through receptors, feedback, controlled comparisons, probability, graph interpretation and explanations that separate mechanism, prediction and clinical utility.
Spatial methods preserve where cells and signals sit within tissue. SIgN’s emphasis on human immunology makes the population, tissue and clinical context central rather than decorative. Chapter 8 follows immune evidence from cells and signals to carefully bounded translational questions, showing students that immunity is a dynamic network shaped by development, exposure, metabolism, microbes, ageing and disease.
Validate segmentation, markers, distances and biological context. A defensible study records the participant or model, tissue, collection time, processing delay, assay panel, reagents, controls, batch, analysis pipeline and meaningful outcome. Flow cytometry, mass cytometry, genomics, imaging and functional assays reveal different layers. Replication and orthogonal measurements help distinguish biology from handling or analytical artefact.
Proximity on an image does not prove communication. Immune data needs cautious interpretation. A cell count, cytokine, antibody or gene-expression signature cannot diagnose a person by itself; group averages may hide heterogeneity; and preclinical results may not transfer to patients. Qualified clinicians, ethics review, regulated trials and current public-health guidance govern real testing, vaccination and treatment.
Explore “Use spatial immune imaging” with a fictional immune-cell dataset or paper network. Define the cell type, tissue, stimulus, measurement, comparator, confounders and validation step, then state what the result cannot support. Draw a spatial hypothesis. Do not collect samples, test allergies, change medicines or infer a real person’s immune status.
Did you know? Immune cells can change their behaviour without changing their broad label, and the same cell type may help in one tissue or phase while contributing to harm in another. Chapter 8 shows why immunologists combine identity, state, location, timing and function instead of treating one marker as the whole immune system.
Capabilities include cell biology, immunology, oncology, microbiology, genomics, microscopy, computational biology, statistics, clinical research, bioengineering and ethics. Current study and career routes set their own entry requirements. School science builds useful foundations through receptors, feedback, controlled comparisons, probability, graph interpretation and explanations that separate mechanism, prediction and clinical utility.
| Evidence move | What to record | What it cannot prove alone |
|---|---|---|
| Measurement platform question | Population, variable, unit and time window | A definition does not establish a result |
| Comparison | Baseline, comparator, controls and uncertainty | Association alone does not establish cause |
| Decision boundary | Owner, trigger, review and escalation | A model does not replace accountable judgement |
Cancer immunity examines recognition, suppression, metabolism and treatment response. SIgN’s emphasis on human immunology makes the population, tissue and clinical context central rather than decorative. Chapter 9 follows immune evidence from cells and signals to carefully bounded translational questions, showing students that immunity is a dynamic network shaped by development, exposure, metabolism, microbes, ageing and disease.
Combine tumour, immune, clinical and longitudinal evidence. A defensible study records the participant or model, tissue, collection time, processing delay, assay panel, reagents, controls, batch, analysis pipeline and meaningful outcome. Flow cytometry, mass cytometry, genomics, imaging and functional assays reveal different layers. Replication and orthogonal measurements help distinguish biology from handling or analytical artefact.
Immune infiltration alone does not predict benefit. Immune data needs cautious interpretation. A cell count, cytokine, antibody or gene-expression signature cannot diagnose a person by itself; group averages may hide heterogeneity; and preclinical results may not transfer to patients. Qualified clinicians, ethics review, regulated trials and current public-health guidance govern real testing, vaccination and treatment.
Explore “Study cancer immunology” with a fictional immune-cell dataset or paper network. Define the cell type, tissue, stimulus, measurement, comparator, confounders and validation step, then state what the result cannot support. Build a tumour-immunity map. Do not collect samples, test allergies, change medicines or infer a real person’s immune status.
Did you know? Immune cells can change their behaviour without changing their broad label, and the same cell type may help in one tissue or phase while contributing to harm in another. Chapter 9 shows why immunologists combine identity, state, location, timing and function instead of treating one marker as the whole immune system.
Capabilities include cell biology, immunology, oncology, microbiology, genomics, microscopy, computational biology, statistics, clinical research, bioengineering and ethics. Current study and career routes set their own entry requirements. School science builds useful foundations through receptors, feedback, controlled comparisons, probability, graph interpretation and explanations that separate mechanism, prediction and clinical utility.
Dysfunction can involve excessive, insufficient, misdirected or poorly resolved responses. SIgN’s emphasis on human immunology makes the population, tissue and clinical context central rather than decorative. Chapter 10 follows immune evidence from cells and signals to carefully bounded translational questions, showing students that immunity is a dynamic network shaped by development, exposure, metabolism, microbes, ageing and disease.
Define phenotype, tissue, trigger and time course. A defensible study records the participant or model, tissue, collection time, processing delay, assay panel, reagents, controls, batch, analysis pipeline and meaningful outcome. Flow cytometry, mass cytometry, genomics, imaging and functional assays reveal different layers. Replication and orthogonal measurements help distinguish biology from handling or analytical artefact.
One inflammatory marker cannot specify a disease mechanism. Immune data needs cautious interpretation. A cell count, cytokine, antibody or gene-expression signature cannot diagnose a person by itself; group averages may hide heterogeneity; and preclinical results may not transfer to patients. Qualified clinicians, ethics review, regulated trials and current public-health guidance govern real testing, vaccination and treatment.
Explore “Investigate immune dysfunction” with a fictional immune-cell dataset or paper network. Define the cell type, tissue, stimulus, measurement, comparator, confounders and validation step, then state what the result cannot support. Create a dysfunction matrix. Do not collect samples, test allergies, change medicines or infer a real person’s immune status.
Did you know? Immune cells can change their behaviour without changing their broad label, and the same cell type may help in one tissue or phase while contributing to harm in another. Chapter 10 shows why immunologists combine identity, state, location, timing and function instead of treating one marker as the whole immune system.
Capabilities include cell biology, immunology, oncology, microbiology, genomics, microscopy, computational biology, statistics, clinical research, bioengineering and ethics. Current study and career routes set their own entry requirements. School science builds useful foundations through receptors, feedback, controlled comparisons, probability, graph interpretation and explanations that separate mechanism, prediction and clinical utility.
Allergy research connects sensitisation, exposure, tissue response and clinical outcomes. SIgN’s emphasis on human immunology makes the population, tissue and clinical context central rather than decorative. Chapter 11 follows immune evidence from cells and signals to carefully bounded translational questions, showing students that immunity is a dynamic network shaped by development, exposure, metabolism, microbes, ageing and disease.
Use validated allergens, controls and governed cohorts. A defensible study records the participant or model, tissue, collection time, processing delay, assay panel, reagents, controls, batch, analysis pipeline and meaningful outcome. Flow cytometry, mass cytometry, genomics, imaging and functional assays reveal different layers. Replication and orthogonal measurements help distinguish biology from handling or analytical artefact.
Sensitisation does not always equal symptomatic allergy. Immune data needs cautious interpretation. A cell count, cytokine, antibody or gene-expression signature cannot diagnose a person by itself; group averages may hide heterogeneity; and preclinical results may not transfer to patients. Qualified clinicians, ethics review, regulated trials and current public-health guidance govern real testing, vaccination and treatment.
Explore “Study allergy” with a fictional immune-cell dataset or paper network. Define the cell type, tissue, stimulus, measurement, comparator, confounders and validation step, then state what the result cannot support. Build an allergy evidence chain. Do not collect samples, test allergies, change medicines or infer a real person’s immune status.
Did you know? Immune cells can change their behaviour without changing their broad label, and the same cell type may help in one tissue or phase while contributing to harm in another. Chapter 11 shows why immunologists combine identity, state, location, timing and function instead of treating one marker as the whole immune system.
Capabilities include cell biology, immunology, oncology, microbiology, genomics, microscopy, computational biology, statistics, clinical research, bioengineering and ethics. Current study and career routes set their own entry requirements. School science builds useful foundations through receptors, feedback, controlled comparisons, probability, graph interpretation and explanations that separate mechanism, prediction and clinical utility.
Ageing changes immune-cell composition, function, memory and tissue context. SIgN’s emphasis on human immunology makes the population, tissue and clinical context central rather than decorative. Chapter 12 follows immune evidence from cells and signals to carefully bounded translational questions, showing students that immunity is a dynamic network shaped by development, exposure, metabolism, microbes, ageing and disease.
Separate chronological age, health, exposure and cohort effects. A defensible study records the participant or model, tissue, collection time, processing delay, assay panel, reagents, controls, batch, analysis pipeline and meaningful outcome. Flow cytometry, mass cytometry, genomics, imaging and functional assays reveal different layers. Replication and orthogonal measurements help distinguish biology from handling or analytical artefact.
Age alone is not a mechanism or destiny. Immune data needs cautious interpretation. A cell count, cytokine, antibody or gene-expression signature cannot diagnose a person by itself; group averages may hide heterogeneity; and preclinical results may not transfer to patients. Qualified clinicians, ethics review, regulated trials and current public-health guidance govern real testing, vaccination and treatment.
Explore “Study immune ageing” with a fictional immune-cell dataset or paper network. Define the cell type, tissue, stimulus, measurement, comparator, confounders and validation step, then state what the result cannot support. Design an ageing comparison. Do not collect samples, test allergies, change medicines or infer a real person’s immune status.
Did you know? Immune cells can change their behaviour without changing their broad label, and the same cell type may help in one tissue or phase while contributing to harm in another. Chapter 12 shows why immunologists combine identity, state, location, timing and function instead of treating one marker as the whole immune system.
Capabilities include cell biology, immunology, oncology, microbiology, genomics, microscopy, computational biology, statistics, clinical research, bioengineering and ethics. Current study and career routes set their own entry requirements. School science builds useful foundations through receptors, feedback, controlled comparisons, probability, graph interpretation and explanations that separate mechanism, prediction and clinical utility.
| Evidence move | What to record | What it cannot prove alone |
|---|---|---|
| Immune dysfunction question | Population, variable, unit and time window | A definition does not establish a result |
| Comparison | Baseline, comparator, controls and uncertainty | Association alone does not establish cause |
| Decision boundary | Owner, trigger, review and escalation | A model does not replace accountable judgement |
Human monoclonal antibodies can become research tools, diagnostics or therapeutic candidates. SIgN’s emphasis on human immunology makes the population, tissue and clinical context central rather than decorative. Chapter 13 follows immune evidence from cells and signals to carefully bounded translational questions, showing students that immunity is a dynamic network shaped by development, exposure, metabolism, microbes, ageing and disease.
Validate specificity, affinity, function, manufacturability and safety. A defensible study records the participant or model, tissue, collection time, processing delay, assay panel, reagents, controls, batch, analysis pipeline and meaningful outcome. Flow cytometry, mass cytometry, genomics, imaging and functional assays reveal different layers. Replication and orthogonal measurements help distinguish biology from handling or analytical artefact.
Binding to a target does not establish clinical benefit. Immune data needs cautious interpretation. A cell count, cytokine, antibody or gene-expression signature cannot diagnose a person by itself; group averages may hide heterogeneity; and preclinical results may not transfer to patients. Qualified clinicians, ethics review, regulated trials and current public-health guidance govern real testing, vaccination and treatment.
Explore “Develop antibodies” with a fictional immune-cell dataset or paper network. Define the cell type, tissue, stimulus, measurement, comparator, confounders and validation step, then state what the result cannot support. Draft an antibody ladder. Do not collect samples, test allergies, change medicines or infer a real person’s immune status.
Did you know? Immune cells can change their behaviour without changing their broad label, and the same cell type may help in one tissue or phase while contributing to harm in another. Chapter 13 shows why immunologists combine identity, state, location, timing and function instead of treating one marker as the whole immune system.
Capabilities include cell biology, immunology, oncology, microbiology, genomics, microscopy, computational biology, statistics, clinical research, bioengineering and ethics. Current study and career routes set their own entry requirements. School science builds useful foundations through receptors, feedback, controlled comparisons, probability, graph interpretation and explanations that separate mechanism, prediction and clinical utility.
Biomarkers require analytical validity, clinical validity and a defined use. SIgN’s emphasis on human immunology makes the population, tissue and clinical context central rather than decorative. Chapter 14 follows immune evidence from cells and signals to carefully bounded translational questions, showing students that immunity is a dynamic network shaped by development, exposure, metabolism, microbes, ageing and disease.
Test across laboratories, cohorts and intended settings. A defensible study records the participant or model, tissue, collection time, processing delay, assay panel, reagents, controls, batch, analysis pipeline and meaningful outcome. Flow cytometry, mass cytometry, genomics, imaging and functional assays reveal different layers. Replication and orthogonal measurements help distinguish biology from handling or analytical artefact.
A significant signature may add no useful decision value. Immune data needs cautious interpretation. A cell count, cytokine, antibody or gene-expression signature cannot diagnose a person by itself; group averages may hide heterogeneity; and preclinical results may not transfer to patients. Qualified clinicians, ethics review, regulated trials and current public-health guidance govern real testing, vaccination and treatment.
Explore “Discover biomarkers” with a fictional immune-cell dataset or paper network. Define the cell type, tissue, stimulus, measurement, comparator, confounders and validation step, then state what the result cannot support. Build a validation plan. Do not collect samples, test allergies, change medicines or infer a real person’s immune status.
Did you know? Immune cells can change their behaviour without changing their broad label, and the same cell type may help in one tissue or phase while contributing to harm in another. Chapter 14 shows why immunologists combine identity, state, location, timing and function instead of treating one marker as the whole immune system.
Capabilities include cell biology, immunology, oncology, microbiology, genomics, microscopy, computational biology, statistics, clinical research, bioengineering and ethics. Current study and career routes set their own entry requirements. School science builds useful foundations through receptors, feedback, controlled comparisons, probability, graph interpretation and explanations that separate mechanism, prediction and clinical utility.
Immunomonitoring tracks biological responses during observational studies or trials. SIgN’s emphasis on human immunology makes the population, tissue and clinical context central rather than decorative. Chapter 15 follows immune evidence from cells and signals to carefully bounded translational questions, showing students that immunity is a dynamic network shaped by development, exposure, metabolism, microbes, ageing and disease.
Predefine time points, assays, outcomes and interpretation rules. A defensible study records the participant or model, tissue, collection time, processing delay, assay panel, reagents, controls, batch, analysis pipeline and meaningful outcome. Flow cytometry, mass cytometry, genomics, imaging and functional assays reveal different layers. Replication and orthogonal measurements help distinguish biology from handling or analytical artefact.
A biological change may not improve how people feel or function. Immune data needs cautious interpretation. A cell count, cytokine, antibody or gene-expression signature cannot diagnose a person by itself; group averages may hide heterogeneity; and preclinical results may not transfer to patients. Qualified clinicians, ethics review, regulated trials and current public-health guidance govern real testing, vaccination and treatment.
Explore “Monitor clinical studies” with a fictional immune-cell dataset or paper network. Define the cell type, tissue, stimulus, measurement, comparator, confounders and validation step, then state what the result cannot support. Create a monitoring schedule. Do not collect samples, test allergies, change medicines or infer a real person’s immune status.
Did you know? Immune cells can change their behaviour without changing their broad label, and the same cell type may help in one tissue or phase while contributing to harm in another. Chapter 15 shows why immunologists combine identity, state, location, timing and function instead of treating one marker as the whole immune system.
Capabilities include cell biology, immunology, oncology, microbiology, genomics, microscopy, computational biology, statistics, clinical research, bioengineering and ethics. Current study and career routes set their own entry requirements. School science builds useful foundations through receptors, feedback, controlled comparisons, probability, graph interpretation and explanations that separate mechanism, prediction and clinical utility.
Human immunology advances through laboratories, hospitals, data teams and participants. SIgN’s emphasis on human immunology makes the population, tissue and clinical context central rather than decorative. Chapter 16 follows immune evidence from cells and signals to carefully bounded translational questions, showing students that immunity is a dynamic network shaped by development, exposure, metabolism, microbes, ageing and disease.
Clarify consent, governance, roles, handoffs and return of results. A defensible study records the participant or model, tissue, collection time, processing delay, assay panel, reagents, controls, batch, analysis pipeline and meaningful outcome. Flow cytometry, mass cytometry, genomics, imaging and functional assays reveal different layers. Replication and orthogonal measurements help distinguish biology from handling or analytical artefact.
Collaboration cannot remove scientific uncertainty. Immune data needs cautious interpretation. A cell count, cytokine, antibody or gene-expression signature cannot diagnose a person by itself; group averages may hide heterogeneity; and preclinical results may not transfer to patients. Qualified clinicians, ethics review, regulated trials and current public-health guidance govern real testing, vaccination and treatment.
Explore “Translate with collaboration” with a fictional immune-cell dataset or paper network. Define the cell type, tissue, stimulus, measurement, comparator, confounders and validation step, then state what the result cannot support. Write a team charter. Do not collect samples, test allergies, change medicines or infer a real person’s immune status.
Did you know? Immune cells can change their behaviour without changing their broad label, and the same cell type may help in one tissue or phase while contributing to harm in another. Chapter 16 shows why immunologists combine identity, state, location, timing and function instead of treating one marker as the whole immune system.
Capabilities include cell biology, immunology, oncology, microbiology, genomics, microscopy, computational biology, statistics, clinical research, bioengineering and ethics. Current study and career routes set their own entry requirements. School science builds useful foundations through receptors, feedback, controlled comparisons, probability, graph interpretation and explanations that separate mechanism, prediction and clinical utility.
The receipt links sample, cell state, assay, cohort, model, outcome and boundary. SIgN’s emphasis on human immunology makes the population, tissue and clinical context central rather than decorative. Chapter 17 follows immune evidence from cells and signals to carefully bounded translational questions, showing students that immunity is a dynamic network shaped by development, exposure, metabolism, microbes, ageing and disease.
Archive panels, reagents, versions, exclusions and uncertainty. A defensible study records the participant or model, tissue, collection time, processing delay, assay panel, reagents, controls, batch, analysis pipeline and meaningful outcome. Flow cytometry, mass cytometry, genomics, imaging and functional assays reveal different layers. Replication and orthogonal measurements help distinguish biology from handling or analytical artefact.
Documentation cannot authorise personal immune conclusions. Immune data needs cautious interpretation. A cell count, cytokine, antibody or gene-expression signature cannot diagnose a person by itself; group averages may hide heterogeneity; and preclinical results may not transfer to patients. Qualified clinicians, ethics review, regulated trials and current public-health guidance govern real testing, vaccination and treatment.
Explore “Keep an immunology receipt” with a fictional immune-cell dataset or paper network. Define the cell type, tissue, stimulus, measurement, comparator, confounders and validation step, then state what the result cannot support. Assemble a one-page receipt. Do not collect samples, test allergies, change medicines or infer a real person’s immune status.
Did you know? Immune cells can change their behaviour without changing their broad label, and the same cell type may help in one tissue or phase while contributing to harm in another. Chapter 17 shows why immunologists combine identity, state, location, timing and function instead of treating one marker as the whole immune system.
Capabilities include cell biology, immunology, oncology, microbiology, genomics, microscopy, computational biology, statistics, clinical research, bioengineering and ethics. Current study and career routes set their own entry requirements. School science builds useful foundations through receptors, feedback, controlled comparisons, probability, graph interpretation and explanations that separate mechanism, prediction and clinical utility.
| Evidence move | What to record | What it cannot prove alone |
|---|---|---|
| Translation question | Population, variable, unit and time window | A definition does not establish a result |
| Comparison | Baseline, comparator, controls and uncertainty | Association alone does not establish cause |
| Decision boundary | Owner, trigger, review and escalation | A model does not replace accountable judgement |
Contents · Previous chapter · Continue in the Science Learning Hub
Primary sources and verification date
Source status for Why Science? | Singapore Immunology Network was checked 11 November 2026. Programmes, platforms, staffing, participation and career routes can change; use the linked official owner for the current edition.
- A*STAR Singapore Immunology Network — Official current institute and technology-platform overview.
- SIgN Research — Official mission, research programmes, platforms and collaboration context.
- SIgN Immune Dysfunctions — Official current themes in homeostasis, allergy, ageing and immunomonitoring.
- SIgN Cancer Immunology — Official cancer-immunology and translational research context.
Continue the evidence journey
Questions families and students often ask
Does one immune test describe the whole immune system?
No. Immune state depends on tissue, timing, method, health context and function.
Why are technology platforms important?
Shared platforms support standardised, specialised measurements and collaboration across studies.
Is inflammation always harmful?
No. Inflammation can support defence and repair, but its timing, intensity, location and resolution matter.
Does a biomarker become a treatment target automatically?
No. Association, mechanism, tractability, safety and demonstrated benefit are separate evidence steps.
What can students practise?
Use safe diagrams, fictional datasets, panel design, controls and evidence ladders without handling human samples.
Human immunology progresses when powerful measurement stays connected to tissue context, functional validation, participant protection and honest limits. Families considering science tuition or a science tutor can use the same evidence questions: what will the learner practise, what feedback will they receive, and how will progress be shown?